Sonja Toblka
⚠️ Moderate Risk
FEI: 3003614317 • Las Condas • CHILE
FEI Number
3003614317
Location
Las Condas
Country
CHILEAddress
Las Malusa 543, , Las Condas, , Chile
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/16/2002 | 66VAY99MISCELLANEOUS PATENT MEDICINES, ETC. | 16DIRECTIONS | New Orleans District Office (NOL-DO) |
Frequently Asked Questions
What is Sonja Toblka's FDA import refusal history?
Sonja Toblka (FEI: 3003614317) has 1 FDA import refusal record(s) in our database, spanning from 4/16/2002 to 4/16/2002.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Sonja Toblka's FEI number is 3003614317.
What types of violations has Sonja Toblka received?
Sonja Toblka has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Sonja Toblka come from?
All FDA import refusal data for Sonja Toblka is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.